Humana Inc. $HUM Shares Bought by Meeder Asset Management Inc.

Meeder Asset Management Inc. raised its holdings in shares of Humana Inc. (NYSE:HUM – Free Report) by 337.1% in the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 2,885 shares of the insurance provider’s stock after acquiring an additional 2,225 shares during the period. Meeder Asset Management Inc.’s holdings in Humana were worth $1,101,000 at the end of the most recent quarter.

Other institutional investors and hedge funds also recently added to or reduced their stakes in the company. BlackRock Inc. purchased a new stake in Humana in the second quarter valued at $4,138,160,000. Pzena Investment Management LLC acquired a new position in shares of Humana in the 2nd quarter valued at about $1,749,014,000. Assenagon Asset Management S.A. lifted its holdings in shares of Humana by 20,126.8% in the 3rd quarter. Assenagon Asset Management S.A. now owns 1,255,479 shares of the insurance provider’s stock valued at $479,053,000 after buying an additional 1,249,272 shares during the period. Legal & General Group Plc purchased a new stake in shares of Humana in the second quarter worth about $329,760,000. Finally, Barrow Hanley Mewhinney & Strauss LLC acquired a new stake in Humana during the second quarter worth about $314,922,000. 92.38% of the stock is currently owned by institutional investors and hedge funds.

Humana Trading Down 1.3%

Shares of Humana stock opened at $380.60 on Friday. The firm has a market capitalization of $45.71 billion, a PE ratio of 29.09, a P/E/G ratio of 1.84 and a beta of 0.65. Humana Inc. has a twelve month low of $163.11 and a twelve month high of $462.87. The firm’s 50-day moving average price is $409.87 and its 200 day moving average price is $321.41. The company has a current ratio of 1.65, a quick ratio of 1.65 and a debt-to-equity ratio of 0.61.

Humana (NYSE:HUM – Get Free Report) last announced its quarterly earnings data on Friday, November 6th. The insurance provider reported ($0.70) earnings per share for the quarter, beating analysts’ consensus estimates of ($1.00) by $0.30. Humana had a return on equity of 8.50% and a net margin of 0.81%. The company had revenue of $41.16 billion for the quarter, compared to analyst estimates of $40.87 billion. During the same quarter last year, the firm posted $3.24 EPS. The firm’s revenue for the quarter was up 26.1% on a year-over-year basis. Humana has set its FY 2026 guidance at 9.500- EPS. On average, sell-side analysts predict that Humana Inc. will post 9.66 EPS for the current fiscal year.

Humana Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Friday, January 29th. Investors of record on Thursday, December 24th will be given a dividend of $0.8850 per share. The ex-dividend date is Thursday, December 24th. This represents a $3.54 dividend on an annualized basis and a yield of 0.9%. Humana’s dividend payout ratio (DPR) is presently 34.44%.

Insiders Place Their Bets

In other Humana news, insider Joseph Ventura sold 5,495 shares of the business’s stock in a transaction on Monday, November 9th. The stock was sold at an average price of $433.85, for a total transaction of $2,384,005.75. Following the transaction, the insider owned 21,910 shares of the company’s stock, valued at approximately $9,505,653.50. The trade was a 20.05% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website. Company insiders own 0.20% of the company’s stock.

Key Stories Impacting Humana

These are some of the HUM stories that stood out recently:

  • Positive Sentiment: A Seeking Alpha opinion piece argues that the proposed CRUSH rule-driven selloff may create a buying opportunity, reflecting a more optimistic interpretation of the policy risk. Humana: The Proposed CRUSH Rule Creates A Buying Opportunity
  • Negative Sentiment: The proposed CMS CRUSH rule would strengthen Medicare Advantage audits and recovery of unsupported risk-adjustment payments, including broader use of extrapolated recoveries. Because Medicare Advantage is central to Humana’s business, investors fear higher repayment exposure and future costs; the proposal has also pressured other health insurers. Humana shares slip after CMS fraud rule
  • Negative Sentiment: SueWallSt announced a pending investigation into whether Humana adequately disclosed its exposure to Medicare Advantage audit and repayment risks. This is an investigation notice, not a finding of wrongdoing, but it adds uncertainty. Humana investigation notice

Analyst Ratings Changes

Several brokerages recently weighed in on HUM. JPMorgan Chase & Co. lifted their price target on Humana from $393.00 to $484.00 and gave the company a “neutral” rating in a research report on Tuesday, November 10th. TD Cowen set a $485.00 price objective on shares of Humana in a research note on Friday. Leerink Partners raised shares of Humana from a “market perform” rating to an “outperform” rating and set a $513.00 target price for the company in a report on Thursday, July 30th. Sanford C. Bernstein reiterated an “outperform” rating and issued a $515.00 target price on shares of Humana in a research note on Tuesday. Finally, Raymond James Financial reissued an “outperform” rating on shares of Humana in a report on Friday, November 6th. One research analyst has rated the stock with a Strong Buy rating, twenty-two have assigned a Buy rating, eight have issued a Hold rating and two have assigned a Sell rating to the company’s stock. According to data from MarketBeat, the stock has an average rating of “Moderate Buy” and a consensus target price of $491.74.

Get Our Latest Research Report on Humana

Humana Company Profile

(Free Report)

Humana Inc. is a U.S. health and wellness company that provides health insurance and healthcare services. Its insurance offerings include Medicare Advantage, Medicare Supplement and prescription drug plans, as well as Medicaid and employer-sponsored plans. The company also provides care through CenterWell, its healthcare services brand, which includes primary care, home health and pharmacy services. Its insurance and care offerings are available in markets across the United States, with availability varying by product and location.

Featured Stories

Want to see what other hedge funds are holding HUM? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Humana Inc. (NYSE:HUM – Free Report).

Institutional Ownership by Quarter for Humana (NYSE:HUM)

Receive News & Ratings for Humana Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Humana and related companies with MarketBeat.com's FREE daily email newsletter.